SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Herbalife Nutrition Ltd. (HLF) trades at a trailing P/E of 6.7, forward P/E of 6.6. Trailing earnings yield is 14.94%, forward earnings yield 15.20%. PEG 0.44 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (80/100, Pass) — P/E is below market average (6.7); PEG ≤ 1.0 — Peter Lynch undervalued (0.44); earnings yield beats bond yields (14.94%).
- Forward P/E 6.6 (down from trailing 6.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.44 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 14.94% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 15.20% as earnings recover.
- Analyst consensus target $16.00 (-4% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 55/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
80/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
25/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HLF
Valuation Multiples
P/E (TTM)6.7
Forward P/E6.6
PEG Ratio0.44
Forward PEG0.44
P/B Ratio-2.97
P/S Ratio0.30
EV/EBITDA6.0
Per Share Data
EPS (TTM)$2.22
Forward EPS (Est.)$2.53
Book Value / Share$-4.96
Revenue / Share$49.00
FCF / Share$2.46
Yields & Fair Value
Earnings Yield14.94%
Forward Earnings Yield15.20%
Dividend Yield0.00%
SharesGrow IV$103.37 (+520.1%)
Analyst Target$16.00 (-4%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
15.4 |
-0.65 |
20.37 |
0.89 |
- |
| 2017 |
25.1 |
-1.79 |
-16.03 |
1.21 |
- |
| 2018 |
29.7 |
0.64 |
-12.18 |
1.80 |
- |
| 2019 |
21.1 |
1.49 |
-16.79 |
1.34 |
- |
| 2020 |
17.0 |
0.67 |
-7.38 |
1.14 |
- |
| 2021 |
9.7 |
0.20 |
-3.11 |
0.75 |
- |
| 2022 |
4.6 |
-0.20 |
-1.16 |
0.28 |
- |
| 2023 |
10.6 |
-0.19 |
-1.42 |
0.30 |
- |
| 2024 |
2.6 |
0.03 |
-0.84 |
0.13 |
- |
| 2025 |
5.8 |
-0.47 |
-2.57 |
0.26 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.51 |
$4.49B |
$260M |
5.8% |
| 2017 |
$1.29 |
$4.43B |
$213.9M |
4.8% |
| 2018 |
$1.98 |
$4.89B |
$296.6M |
6.1% |
| 2019 |
$2.20 |
$4.88B |
$311M |
6.4% |
| 2020 |
$2.77 |
$5.54B |
$372.6M |
6.7% |
| 2021 |
$4.13 |
$5.8B |
$447.2M |
7.7% |
| 2022 |
$3.23 |
$5.2B |
$321.3M |
6.2% |
| 2023 |
$1.42 |
$5.06B |
$142.2M |
2.8% |
| 2024 |
$2.50 |
$4.99B |
$254.3M |
5.1% |
| 2025 |
$2.20 |
$5.04B |
$228.3M |
4.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$2.55 |
$2.38 – $2.71 |
$5.23B |
$5.22B – $5.24B |
2 |
| 2027 |
$3.05 |
$2.75 – $3.34 |
$5.44B |
$5.43B – $5.45B |
2 |
| 2028 |
$0.00 |
$0.00 – $0.00 |
$5.91B |
$5.85B – $5.97B |
1 |
